Introduction: Staphylococcus aureus is an important pathogen responsible for hospital and community acquired infection(s). Emerging resistance
Introduction
Staphylococcus aureus is one of the organisms most frequently encountered in hospital and community acquired infection, especially in elderly individuals [1] ; rates of Staphylococcus aureus infection have increased during the past 2 decades [2] . Bacteremia due to S. aureus has been reported to be associated with mortality rates of 15%-60% [3] . Infections with antibiotic-resistant organisms are thought to result in higher morbidity and mortality rates than are similar infections with antibiotic-susceptible strains [4] . In the early 1940s the introduction of benzylpenicillin (penicillin G) temporarily solved the problem of staphylococcal infections, but the continued use of this agent caused the selection of resistant strains, which produced penicillinase (β-lactamase) [5] . Resistance to methicillin among S. aureus isolates is a growing problem and poses a significant threat for effective treatment of several difficult-to-treat infections in humans [6] . High mortality rates associated to MRSA have been reported. According to the National Strategy for Combating Antibiotic Resistant Bacteria [7] , there were more than 80,000 invasive MRSA infections and 11,285 related deaths in 2011. An understanding of the magnitude of the problem requires national studies to estimate the incidence of the infection and to identify antibiotic resistance. In Cameroon, there is a paucity of data on this public health issue. The aim of this study was to determine the antibiotic susceptibility patterns of Staphylococcus aureus's strains isolated at the Yaounde Central Hospital, Cameroon. resistance phenotypes were identified as described by Courvalin et al [12] . The quality control of discs used was performed using Staphylococcus aureus (ATCC 25923).
Methods
Data analysis: data were entered and analyzed using SPSS version 16 .0 for windows (SPSS, Inc., Chicago, IL). Discrete variables were compared using the Chi-square test. Statistical significance difference was considered at value of p < 0.05.
Results
In total, 250 non repeated strains of S. aureus were included in the study. 19 which is the first-line antibiotic for MRSA bacteremia treatment. This result contrasts with those reported by Karimi et al [23] and Swanston [24] where MRSA isolates were found susceptible to vancomycin. The high resistance of isolates to antibiotics could be due to the wide use of these drugs for the treatment of staphylococcal infections in our set up, as wide consumption of antibiotics results to the emergence of antibiotics resistant Staphylococcus species due to selective pressure.
In this study the rate of iMLSB among MSRA was found to be 4.5%.
Varying prevalence rates of iMLSB have been reported in different other studies; 2.1% from Brazil [25] , 8% from Jamaica [26] , 18.2% from Nepal [27] , 25% from Cameroon [1] , 28.6% from Iran [28], 20.7% [29] and 24.3% [30] from India. Higher iMLSB prevalence of 37.5% from India [31] and 91% from Japan [32] has also been reported. A comparatively low prevalence of inducible resistance in this study could be due to the geographical variations of circulatory clones. MRSA isolates showed high rates of resistance to aminoglycoside agents. The study of resistance phenotypes of our MRSA to these drugs showed three types. 9 strains (4.5%) had a phenotype K, due to the production of the enzyme-Aminoglycoside phosphotransferase APH (3')-III. 30(14.9%) were resistant to kanamycin and tobramycin, KT is the phenotype expressed by the production of the enzyme-Aminoglycosides nucleotidyltransferases ANT (4') (4"), while 85 strains (42.3%) expressed the KTG phenotype and were resistant to the three antibiotics (kanamycin, tobramycin, gentamicin) due to the bifunctional enzyme APH (2") -Aminoglycosides acetyltransferases AAC (6') [33] . Our results are supported by those of Ida et al [34] and Shaw et al [35] who showed that most MRSA isolates seemed likely to produce AAC(6')/APH(2"), with or without ANT(4')-I, among the five kinds of aminoglycoside-modifying enzymes. In general, a beta-lactam or vancomycin often is combined with an aminoglycoside due to their synergistic effect and increased rates of killing in serious staphylococcal infections [36] . However, considering the high rates of resistance to the aminoglycosides, the addition of an aminoglycoside for the treatment of MRSA infections may be unpredictable in our set up.
Conclusion
The 
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